By Iain Gilbert
Date: Wednesday 06 Nov 2024
(Sharecast News) - Analysts at Berenberg downgraded medical equipment manufacturing company Smith & Nephew from 'buy' to 'hold' and lowered its target price on the stock from £14.50 to £10.50, stating the group's path to recovery was now "less clear".
Berenberg said Smith & Nephew released "a disappointing Q3 trading...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news